Loading the recordsβ¦
Loading the recordsβ¦

Kelly Louise Morrison (D-MN) sold $15K-$50K of $ZBRA (Zebra Technologies Corporation Class A Common Stock) on Jun 4, 2025, part of 8 transactions in this filing (1 buys, 7 sells).
How the largest positions have moved from the trade date to the most recent close.
See the full trade breakdown, suspicious timing flags, and how this filing connects to active legislation.
Get Free Access β| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | Government Securities | MINNESOTA ST MUNI PWR AGY ELEC DTD 08/25/16(Government Securities) | $1K-$15K | β | β | β | Apr 1, 2025 |
| SELL | $ZBRA | Zebra Technologies Corporation Class A Common Stock | $15K-$50K | $291.03 | $255.81 | -12.1% | Jun 4, 2025 |
| SELL | $HLI | Houlihan Lokey, Inc. Class A Common Stock | $1K-$15K | $174.02 | $132.92 | -23.6% | Jun 4, 2025 |
| SELL | $RMD | ResMed Inc. Common Stock | $1K-$15K | $249.94 | $198.43 | -20.6% | Jun 4, 2025 |
| SELL | $UPS | United Parcel Service, Inc. Common Stock | $1K-$15K | $98.55 | $108.01 | +9.6% | Jun 4, 2025 |
| SELL | $WEX | WEX Inc. common stock | $1K-$15K | $138.28 | $136.73 | -1.1% | Jun 4, 2025 |
| SELL | $ZBRA | Zebra Technologies Corporation Class A Common Stock | $1K-$15K | $291.03 | $255.81 | -12.1% | Jun 4, 2025 |
| SELL | $NKE | Nike, Inc. Common Stock | $1K-$15K | $62.77 | $41.48 | -33.9% | Jun 4, 2025 |
These bills and contracts share tickers or sectors with this filing's trades.
The CREATE JOBS Act (S.2056) proposes permanently reinstating 100% bonus depreciation for all U.S. businesses, a proven tax incentive reducing the after-tax cost of capital equipment by 21% in year one. At current market prices, capital-intensive companies like CAT ($810.05), DE ($560.02), FDX ($388.59), and AMZN ($263.04) have already shown strong 30-day momentum (CAT +21.37%, FDX +13.7%, AMZN +30.9%), reflecting broader economic expectations this tax policy reinforces. The bill is in early committee stage with legislative risk high, but identical House companion HR3967 improves odds of eventual enactment.
S.2677 is an early-stage procedural bill that expands CBP's authority to share IP violation data with rights holders. It imposes minimal compliance obligations on marketplaces and carriers but has zero appropriated funding. This bill has no material market-moving potential for any company. Retail investors should ignore this legislation for trading decisions.
S. 1381 (Protecting Employees and Retirees in Business Bankruptcies Act of 2025) is an early-stage Senate bill that would structurally increase bankruptcy costs for labor-intensive companies. For UAL and GM, the bill elevates employee and retiree claims in Chapter 11, raising bankruptcy risk premiums. At impact score 3, near-term market effects are minimal, but the structural risk is real if the bill advances through the Judiciary Committee.
HR747 (Stop Chinese Fentanyl Act) is an early-stage House bill expanding sanctions definitions for Chinese entities involved in opioid precursors. The bill has been reported by committee but faces a long legislative path. Market data shows chemicals ($DD, $ECL) are near 30-day lows while logistics ($UPS, $FDX, $CHRW) have rallied 12-15% in the last month, indicating no market pricing of this bill's risk. Impact score is low at 2 because the bill authorizes zero funding, remains early-stage, and would affect a narrow subset of US-China chemical trade.
Free β no credit card
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter β before they hit the news.
Weekly digest β the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan Β· No credit card Β· Unsubscribe in one click
Want the live terminal too? Create a free account β
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.